{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:49:46Z","timestamp":1761976186018,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10147-025-02810-5","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:33:59Z","timestamp":1751852039000},"page":"1757-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study"],"prefix":"10.1007","volume":"30","author":[{"given":"Keisuke","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sakakibara-Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3762-2391","authenticated-orcid":false,"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2810_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/222385a0","volume":"222","author":"B Rosenberg","year":"1969","unstructured":"Rosenberg B, VanCamp L, Trosko JE et al (1969) Platinum compounds: a new class of potent antitumour agents. Nature 222:385\u2013386. https:\/\/doi.org\/10.1038\/222385a0","journal-title":"Nature"},{"key":"2810_CR2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.mayocp.2019.01.034","volume":"94","author":"S Wang","year":"2019","unstructured":"Wang S, Zimmermann S, Parikh K et al (2019) Current diagnosis and management of small-cell lung cancer. Mayo Clin Proc 94:1599\u20131622. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.034","journal-title":"Mayo Clin Proc"},{"key":"2810_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00520-016-3426-5","volume":"25","author":"Y Saito","year":"2017","unstructured":"Saito Y, Kobayashi M, Yamada T et al (2017) Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity. Support Care Cancer 25:481\u2013487. https:\/\/doi.org\/10.1007\/s00520-016-3426-5","journal-title":"Support Care Cancer"},{"key":"2810_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/jjco\/hyu004","volume":"44","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Niho S, Toda M et al (2014) Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study. Jpn J Clin Oncol 44:346\u2013354. https:\/\/doi.org\/10.1093\/jjco\/hyu004","journal-title":"Jpn J Clin Oncol"},{"key":"2810_CR5","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1038\/s41598-022-26454-x","volume":"12","author":"Y Saito","year":"2022","unstructured":"Saito Y, Sakamoto T, Takekuma Y et al (2022) Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis. Sci Rep 12:21819. https:\/\/doi.org\/10.1038\/s41598-022-26454-x","journal-title":"Sci Rep"},{"key":"2810_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232\u2013235. https:\/\/doi.org\/10.1038\/newbio231232a0","journal-title":"Nat New Biol"},{"key":"2810_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0090-6980(02)00028-X","volume":"68\u201369","author":"CD Loftin","year":"2002","unstructured":"Loftin CD, Tiano HF, Langenbach R (2002) Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Other Lipid Mediat 68\u201369:177\u2013185. https:\/\/doi.org\/10.1016\/S0090-6980(02)00028-X","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2810_CR8","unstructured":"World Health Organization (1996) Cancer pain relief\u202f: with a guide to opioid availability, 2nd edn. World Health Organization, Geneva. https:\/\/iris.who.int\/handle\/10665\/37896"},{"key":"2810_CR9","doi-asserted-by":"publisher","unstructured":"Okamoto K, Saito Y, Narumi K et al (2020) Non-steroidal anti-inflammatory drugs are a risk factor for cisplatin-induced nephrotoxicity: a meta-analysis of retrospective studies. Anticancer Res 40:1747\u20131751. https:\/\/doi.org\/10.21873\/anticanres.14128","DOI":"10.21873\/anticanres.14128"},{"key":"2810_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173339","volume":"884","author":"K Okamoto","year":"2020","unstructured":"Okamoto K, Saito Y, Narumi K et al (2020) Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo. Eur J Pharmacol 884:173339. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173339","journal-title":"Eur J Pharmacol"},{"key":"2810_CR11","doi-asserted-by":"publisher","unstructured":"Saito Y, Takekuma Y, Kobayashi M et al (2022) Suitability of oral rehydration solution (ORS) for use in the cisplatin short hydration method. Anticancer Res 42:3185\u20133193. https:\/\/doi.org\/10.21873\/anticanres.15808","DOI":"10.21873\/anticanres.15808"},{"key":"2810_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00280-016-2966-1","volume":"77","author":"Y Funakoshi","year":"2016","unstructured":"Funakoshi Y, Fujiwara Y, Kiyota N et al (2016) Validity of new methods to evaluate renal function in cancer patients treated with cisplatin. Cancer Chemother Pharmacol 77:281\u2013288. https:\/\/doi.org\/10.1007\/s00280-016-2966-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"2810_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/medicina58010046","volume":"58","author":"A El-Sheikh","year":"2021","unstructured":"El-Sheikh A, Khired Z (2021) Interactions of analgesics with cisplatin: modulation of anticancer efficacy and potential organ toxicity. Medicina (Kaunas) 58:46. https:\/\/doi.org\/10.3390\/medicina58010046","journal-title":"Medicina (Kaunas)"},{"key":"2810_CR14","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I et al (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 96:7563\u20137568. https:\/\/doi.org\/10.1073\/pnas.96.13.7563","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2810_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","volume":"89","author":"GP Kaushal","year":"2016","unstructured":"Kaushal GP, Shah SV (2016) Autophagy in acute kidney injury. Kidney Int 89:779\u2013791. https:\/\/doi.org\/10.1016\/j.kint.2015.11.021","journal-title":"Kidney Int"},{"key":"2810_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2019.02.006","volume":"163","author":"N Rashtchizadeh","year":"2019","unstructured":"Rashtchizadeh N, Argani H, Ghorbanihaghjo A et al (2019) AMPK: a promising molecular target for combating cisplatin toxicities. Biochem Pharmacol 163:94\u2013100. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.006","journal-title":"Biochem Pharmacol"},{"key":"2810_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1681\/ASN.2018100983","volume":"30","author":"S Sakai","year":"2019","unstructured":"Sakai S, Yamamoto T, Takabatake Y et al (2019) Proximal tubule autophagy differs in type 1 and 2 diabetes. J Am Soc Nephrol 30:929\u2013945. https:\/\/doi.org\/10.1681\/ASN.2018100983","journal-title":"J Am Soc Nephrol"},{"key":"2810_CR18","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G et al (2010) Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2:2490\u20132518. https:\/\/doi.org\/10.3390\/toxins2112490","journal-title":"Toxins (Basel)"},{"key":"2810_CR19","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1152\/ajprenal.00199.2018","volume":"315","author":"Y Fu","year":"2018","unstructured":"Fu Y, Tang C, Cai J et al (2018) Rodent models of AKI-CKD transition. Am J Physiol Renal Physiol 315:1098\u20131106. https:\/\/doi.org\/10.1152\/ajprenal.00199.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"2810_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1681\/ASN.2020101455","volume":"32","author":"SM Sears","year":"2021","unstructured":"Sears SM, Siskind LJ (2021) Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis. J Am Soc Nephrol 32:1559\u20131567. https:\/\/doi.org\/10.1681\/ASN.2020101455","journal-title":"J Am Soc Nephrol"},{"key":"2810_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/biom12081078","volume":"12","author":"A Iskander","year":"2022","unstructured":"Iskander A, Yan L-J (2022) Cisplatin-induced kidney toxicity: potential roles of major NAD+-dependent enzymes and plant-derived natural products. Biomolecules 12:1078. https:\/\/doi.org\/10.3390\/biom12081078","journal-title":"Biomolecules"},{"key":"2810_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/cells12030412","volume":"12","author":"M Ruby","year":"2023","unstructured":"Ruby M, Gifford CC, Pandey R et al (2023) Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-\u03b21 in autophagy and kidney fibrosis. Cells 12:412. https:\/\/doi.org\/10.3390\/cells12030412","journal-title":"Cells"},{"key":"2810_CR23","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/jcm12072467","volume":"12","author":"CT Han","year":"2023","unstructured":"Han CT, Islam MM, Poly TN et al (2023) A meta-analysis of proton pump inhibitor use and the risk of acute kidney injury: geographical differences and associated factors. J Clin Med 12:2467. https:\/\/doi.org\/10.3390\/jcm12072467","journal-title":"J Clin Med"},{"key":"2810_CR24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s10147-024-02629-6","volume":"29","author":"K Okamoto","year":"2024","unstructured":"Okamoto K, Saito Y, Yamaguchi A et al (2024) Relationship between magnesium dosage and the preventive effect on cisplatin-induced nephrotoxicity: meta-analysis and meta-regression analysis. Int J Clin Oncol 29:1817\u20131824. https:\/\/doi.org\/10.1007\/s10147-024-02629-6","journal-title":"Int J Clin Oncol"},{"key":"2810_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejphar.2017.05.034","volume":"811","author":"Y Saito","year":"2017","unstructured":"Saito Y, Okamoto K, Kobayashi M et al (2017) Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters. Eur J Pharmacol 811:191\u2013198. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.034","journal-title":"Eur J Pharmacol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02810-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:12:41Z","timestamp":1756390361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02810-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}